Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02624947
What this trial is testing

Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 4,636
Early research (Phase 1)Study completedNCT03387137
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT02202356
What this trial is testing

ALS-008176 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 183
Not applicableStudy completedNCT03757429
What this trial is testing

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus

Who this might be right for
Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Uppsala University 31
Early research (Phase 1)Study completedNCT00493285
What this trial is testing

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Who this might be right for
Respiratory Viral InfectionsRespiratory Syncytial Virus InfectionsParainfluenza Virus 3, Human
MedImmune LLC 49
Not applicableStudy completedNCT06229444
What this trial is testing

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

Who this might be right for
InfluenzaInfluenza AInfluenza B+2 more
Evidation Health 17,043
Large-scale testing (Phase 3)Study completedNCT04841577
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 976
Testing effectiveness (Phase 2)WithdrawnNCT03191383
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Early research (Phase 1)Study completedNCT01230645
What this trial is testing

RV568 - Viral Challenge With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Respivert Ltd 42
Not applicableStudy completedNCT00585481
What this trial is testing

Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infection
Abbott 310
Early research (Phase 1)Study completedNCT06328400
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Who this might be right for
Respiratory Syncytial Virus Infections
Vigonvita Life Sciences 24
Not applicableUnknownNCT03621930
What this trial is testing

RESCEU Study, Defining the Burden of Disease of RSV in Older Adults

Who this might be right for
RSV InfectionRespiratory Syncytial Virus InfectionsBronchiolitis
UMC Utrecht 1,040
Testing effectiveness (Phase 2)Study completedNCT04491877
What this trial is testing

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
Respiratory Syncytial Virus Infection
Sanofi Pasteur, a Sanofi Company 259
Testing effectiveness (Phase 2)Study completedNCT02360475
What this trial is testing

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 507
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Study completedNCT01065935
What this trial is testing

Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Alnylam Pharmaceuticals 87
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07633288
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Who this might be right for
Respiratory Viral Infection
SynAct Pharma Aps 96
Testing effectiveness (Phase 2)Study completedNCT06143046
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT02247726
What this trial is testing

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 50
Next Page